Melinda Magyari

Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis

Tim Spelman, Melinda Magyari, Fredrik Piehl et al. · JAMA Neurology · 2021 · 234 citations · Full text

Education, Neurology, Disability Management +13

Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women

Nils Koch‐Henriksen, Lau Caspar Thygesen, Egon Stenager et al. · Neurology · 2018 · 181 citations

Veterinary Medicine, Neurology, Disease Surveillance +8

Initial high-efficacy disease-modifying therapy in multiple sclerosis

Mathias Due Buron, Thor Ameri Chalmer, Finn Sellebjerg et al. · Neurology · 2020 · 159 citations

Medicine, Neurology, Comparative Effectiveness Research +13

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis

Steve Simpson, Edward De Brouwer, Tomáš Kalinčík et al. · Cronfa (Swansea University) · 2021 · 157 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +16

Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop

Maria Pia Amato, Bernard Hemmer, Roland Liblau et al. · Multiple Sclerosis Journal · 2017 · 142 citations · Full text

Life Sciences, Neurology, Neuroscience +16